ANXA9 and breast cancer: In three BC cell lines, downregulation of ANXA9 protein levels decreased phosphorylation of AKT, mTOR expression, and STAT3 phosphorylation, whereas the total protein level of AKT and STAT3 was not affected (Fig. 6G).